X-Therma CEO Dr. Xiaoxi Wei is invited to give a plenary talk and a presentation at the CRYO this July in China

X-Therma CEO Dr. Xiaoxi Wei is invited to give a plenary talk and a section presentation on our new generation of cryoprotectants for the regenerative medicine industry at the CRYO17 Meeting in Hefei, China

 

X-Therma is selected by the California Institute of Regenerative Medicine (CIRM) for highly competitive funding

X-Therma is selected by the California Institute of Regenerative Medicine (CIRM) for highly competitive funding to fuel X-Therma’s development to advance critical stem cell manufacturing processes.

 

X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract

X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract. X-Therma’s CryomatrixTM is a new pipeline of non-toxic and hyper-effective cryoprotectants in development for cell, tissue, and organ banking.

 

X-Therma CEO Dr. Xiaoxi Wei’s career development story is featured in Chemical &Engineering News

X-Therma CEO Dr. Xiaoxi Wei’s career development story is featured in Chemical &Engineering News (C&EN, Volume 95 Issue 23 | p. 23| Issue Date: June 5, 2017). An enlightening story of her inspiration to start the startup journey guided by a childhood dream.

http://cen.acs.org/articles/95/i23/Career-Ladder-Xiaoxi-Wei.html

 

X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract

X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract. This contract funds genitourinary organ transplants performed with XT-ViVoTM  cryopreserved tissue.

 

X-Therma CEO Dr. Xiaoxi Wei was an invited speaker to give an inspirational talk at Women chemists Committee (WCC)

X-Therma CEO Dr. Xiaoxi Wei was an invited speaker to give an inspirational talk at Women chemists Committee (WCC) on entrepreneurship at the WCC in Chemical Enterprise Breakfast for the American Chemical Society, the world’s largest scientific society.

 

X-Therma CEO Dr. Xiaoxi Wei is giving a talk at Younger Chemists Committee (YCC) national symposium

X-Therma CEO Dr. Xiaoxi Wei is giving a talk at Younger Chemists Committee (YCC) national symposium about entrepreneurship and careers in Chemistry at the American Chemical Society national convention in San Francisco, CA.

X-Therma has been selected as a cohort member of the California Life Science Association FAST Advisory program.

The FAST Advisory Program provides select entrepreneurs with intensive team review and coaching to perfect their business model, product development plans, and to build a compelling commercialization strategy. Experienced entrepreneurs, product and business experts (which may include clinical development, regulatory, reimbursement and business development specialists) will advise selected Fellows during a ten-to-twelve week program, culminating in a Final FAST Showcase to a broad audience that includes potential investors and partners.

Mauldin Economics covered X-Therma’s vision for Organ Banking

Mauldin Economics covered X-Therma’s vision for Organ Banking in their monthly TransTech Alert, written by best-selling author, Wall Street analyst, and financial writer John Mauldin and Patrick Cox. From Arctic fish to biomimetic nanotechnology, X-Therma is defeating ice to save millions of lives.

 

X-Therma is featured in “Wirtschaftswoche” – Top weekly magazine in German Economy

X-Therma is featured in “Wirtschaftswoche“ – top weekly magazine in German Economy.

—59 Valley Talk: Investoren begeistern sich für Transplantationstechnik, WirtschaftsWoche Ausgabe 42/2016

 

13123